n/a
Article Publish Status: FREE
Abstract Title:

Blueberry Supplementation in Midlife for Dementia Risk Reduction.

Abstract Source:

Nutrients. 2022 Apr 13 ;14(8). Epub 2022 Apr 13. PMID: 35458181

Abstract Author(s):

Robert Krikorian, Matthew R Skelton, Suzanne S Summer, Marcelle D Shidler, Patrick G Sullivan

Article Affiliation:

Robert Krikorian

Abstract:

Late-life dementia typically develops over a period of many years beginning in midlife. Prevalence of metabolic disturbance also accelerates in middle age and is a prominent risk factor for dementia. Preliminary studies indicate that blueberry supplementation can improve cognitive performance and influence metabolism and brain function and therefore may have a role in early intervention to prevent neurodegeneration. In a randomized controlled trial, we investigated the effects of daily blueberry supplementation in a middle-aged sample of insulin-resistant participants with elevated risk for future dementia. We enrolled overweight men and women, aged 50 to 65 years, with subjective cognitive decline (SCD) and performed pre- and post-intervention assessments of cognition and metabolism and exploratory measures of peripheral mitochondrial function. We observed improved performances for the blueberry group on measures of lexical access,= 0.003, and memory interference,= 0.04, and blueberry-treated participants reported reduced memory encoding difficulty in daily life activities,= 0.03. The blueberry-treated group also exhibited correction of peripheral hyperinsulinemia,= 0.04, and a modest trend for increased mitochondrial uncoupling,= 0.11. The cognitive findings indicated improved executive ability in this middle-aged sample. In addition, the changes in metabolic and bioenergetic measures imply potential mechanistic factors associated with anthocyanin and proanthocyanidin actions. The demonstration of these benefits in middle-aged individuals with insulin resistance and SCD suggests that ongoing blueberry supplementation may contribute to protection against cognitive decline when implemented early in at-risk individuals.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.